- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/487 - Physical analysis of biological material of liquid biological material
Patent holdings for IPC class G01N 33/487
Total number of patents in this class: 5332
10-year publication summary
410
|
526
|
541
|
475
|
459
|
444
|
381
|
331
|
294
|
157
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Roche Sequencing Solutions, Inc. | 644 |
215 |
F. Hoffmann-La Roche AG | 7930 |
198 |
Roche Diagnostics GmbH | 2688 |
131 |
Oxford NanoPore Technologies plc | 320 |
100 |
The Regents of the University of California | 19887 |
94 |
Ascensia Diabetes Care Holdings AG | 596 |
80 |
Abbott Diabetes Care Inc. | 2016 |
76 |
Roche Diabetes Care, Inc. | 1493 |
73 |
Oxford NanoPore Technologies Limited | 272 |
72 |
Bayer HealthCare LLC | 1361 |
59 |
President and Fellows of Harvard College | 5972 |
55 |
Illumina, Inc. | 3340 |
52 |
Siemens Healthcare Diagnostics Inc. | 2043 |
49 |
Arizona Board of Regents on behalf of Arizona State University | 2612 |
43 |
PHC Holdings Corporation | 719 |
42 |
Roche Diagnostics Operations, Inc. | 1486 |
40 |
International Business Machines Corporation | 61198 |
38 |
LifeScan Scotland Limited | 112 |
30 |
University of Washington | 2322 |
27 |
The Trustees of Columbia University in the City of New York | 3565 |
26 |
Other owners | 3832 |